| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5122625 | Le Pharmacien Hospitalier et Clinicien | 2017 | 8 Pages |
Abstract
This study confirms the results reported by Leroy et al. In the current context, where time for pharmaceutical analysis is increasingly limited, this selective approach enables activity to be focused on potentially high-risk prescriptions.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
M. Philippe, E. Jean-Bart, J. Coutet, M. Bourdelin, C. Renzullo, S. Coursier, H. Bontemps, B. Leroy,